Wilson Sonsini advised MasterControl on the deal while Sidley represented Sixth Street Growth. MasterControl, a leading provider of quality and manufacturing software solutions for the life...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised lead investors Optum Ventures and Oxford Science Enterprises on the deal. Virtual reality mental and behavioral health companies BehaVR and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk & Wardwell advised the representatives of the several underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction. Clinical-stage biotechnology company Arcellx and Gilead-owned biopharmaceutical company Kite announced a global strategic collaboration to develop...
You must be a Standard 1 Year member to access this content.
Freshfields advised Ericsson on the deal while Wilson Sonsini advised Aeris Communications. Ericsson (NASDAQ: ERIC) and Aeris Communications, a leading provider of Internet of Things (IoT)...
You must be a Standard 1 Year member to access this content.
O’Melveny advised the sponsors and underwriters on the listing, while Wilson Sonsini Goodrich & Rosati and Maples and Calder represented Huafang. Huafang Group Inc. announced the IPO...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati acted as TuanChe’s U.S. counsel in this transaction. TuanChe Limited, a leading integrated automotive marketplace in China, announced the closing of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cajal Neuroscience on the deal. Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Maven Clinic on the deal. Maven Clinic, one of the largest virtual clinics in women’s and family health, announced that it raised a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised NEA and Abingworth on the transaction. Escient Pharmaceuticals announced that it had raised $120 million through a Series C Financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised CalciMedica on the deal. Graybug Vision, Inc. and CalciMedica Inc. announced that they have entered into a definitive merger agreement to combine the...
You must be a Standard 1 Year member to access this content.
